Sitemap

February 09, 2006 Articles

Filter by Available Specialty
  1. Alcon reports 2005 global sales of $4.37 billion
  2. Intravitreal gene therapy shows promise in early-stage trial
  3. Optos plans to go public
  4. Study links gene defect and increased osteoporosis risk
  5. Vitrectomy for diabetic macular edema may be limited